BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 24, 2004
View Archived Issues
Safety Issues Force IntraBiotics To Halt Iseganan VAP Program
Just as researchers geared up to start a second pivotal trial of iseganan in ventilator-associated pneumonia (VAP), the floor fell from beneath IntraBiotics Pharmaceuticals Inc. Wednesday. (BioWorld Today)
Read More
Exelixis Begins Phase III Trial Of XL119 In Bile Duct Cancer
Read More
PTC Raises Another $15M To Close Series E At $50M
Read More
Millennium Shifts Integrilin In Europe From Schering To GSK
Read More
Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate
Read More
Other News To Note
Read More